GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Diplomat Pharmacy Inc (NYSE:DPLO) » Definitions » Inventory-to-Revenue

Diplomat Pharmacy (Diplomat Pharmacy) Inventory-to-Revenue : 0.14 (As of Sep. 2019)


View and export this data going back to 2014. Start your Free Trial

What is Diplomat Pharmacy Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Diplomat Pharmacy's Average Total Inventories for the quarter that ended in Sep. 2019 was $180 Mil. Diplomat Pharmacy's Revenue for the three months ended in Sep. 2019 was $1,301 Mil. Diplomat Pharmacy's Inventory-to-Revenue for the quarter that ended in Sep. 2019 was 0.14.

Diplomat Pharmacy's Inventory-to-Revenue for the quarter that ended in Sep. 2019 increased from Jun. 2019 (0.14) to Jun. 2019 (0.14)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Diplomat Pharmacy's Days Inventory for the three months ended in Sep. 2019 was 13.29.

Inventory Turnover measures how fast the company turns over its inventory within a year. Diplomat Pharmacy's Inventory Turnover for the quarter that ended in Sep. 2019 was 6.87.


Diplomat Pharmacy Inventory-to-Revenue Historical Data

The historical data trend for Diplomat Pharmacy's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diplomat Pharmacy Inventory-to-Revenue Chart

Diplomat Pharmacy Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Inventory-to-Revenue
Get a 7-Day Free Trial 0.04 0.04 0.04 0.05 0.04

Diplomat Pharmacy Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.14 0.15 0.14 0.14

Competitive Comparison of Diplomat Pharmacy's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Diplomat Pharmacy's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diplomat Pharmacy's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Diplomat Pharmacy's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Diplomat Pharmacy's Inventory-to-Revenue falls into.



Diplomat Pharmacy Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Diplomat Pharmacy's Inventory-to-Revenue for the fiscal year that ended in Dec. 2018 is calculated as

Inventory-to-Revenue (A: Dec. 2018 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2017 ) + Total Inventories (A: Dec. 2018 )) / count ) / Revenue (A: Dec. 2018 )
=( (206.603 + 210.573) / 2 ) / 5492.524
=208.588 / 5492.524
=0.04

Diplomat Pharmacy's Inventory-to-Revenue for the quarter that ended in Sep. 2019 is calculated as

Inventory-to-Revenue (Q: Sep. 2019 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jun. 2019 ) + Total Inventories (Q: Sep. 2019 )) / count ) / Revenue (Q: Sep. 2019 )
=( (179.083 + 181.401) / 2 ) / 1301.197
=180.242 / 1301.197
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diplomat Pharmacy  (NYSE:DPLO) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Diplomat Pharmacy's Days Inventory for the three months ended in Sep. 2019 is calculated as:

Days Inventory=Average Total Inventories (Q: Sep. 2019 )/Cost of Goods Sold (Q: Sep. 2019 )*Days in Period
=180.242/1237.812*365 / 4
=13.29

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Diplomat Pharmacy's Inventory Turnover for the quarter that ended in Sep. 2019 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2019 ) / Average Total Inventories (Q: Sep. 2019 )
=1237.812 / 180.242
=6.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diplomat Pharmacy Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Diplomat Pharmacy's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Diplomat Pharmacy (Diplomat Pharmacy) Business Description

Traded in Other Exchanges
N/A
Address
4100 South Saginaw Street, Flint, MI, USA, 48507
Diplomat Pharmacy Inc. is active in the U.S. healthcare sector. It provides specialty pharmacy and infusion services, including pharmacy solutions for chronic diseases. The company has two main segments: specialty pharmacy and pharmacy benefit management. Its specialty pharmacy segment offers solutions to dispense, deliver, and dose prescription drugs. The pharmacy benefit management segment offers services to help control pharmacy benefit dollars and maximize quality of care. It derives most of its revenue through prescription drug sales in the United States.
Executives
Brian T Griffin director, officer: Chairman and CEO
David C Dreyer director C/O SICOR INC, 19 HUGHES, IRVINE CA 92618-1902
Shawn Tomasello director C/O PHARMACYCLICS, INC, 995 EAST ARQUES AVENUE, SUNNYVALE CA 94085
Regina M. Benjamin director 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Benjamin Wolin director C/O EVERYDAY HEALTH, INC., 345 HUDSON STREET, 16TH FLOOR, NEW YORK NY 10014
Jeffrey G Park director C/O DIPLOMAT PHARMACY, INC., 4100 S. SAGINAW ST., FLINT MI 48507
Sean Whelan director, officer: Chief Financial Officer C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108
Jeffrey M Rowe director, officer: EVP of Operations C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018

Diplomat Pharmacy (Diplomat Pharmacy) Headlines

From GuruFocus